BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of the efficacy of intravesical cisplatin in superficial bladder tumors]. 1984

A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva

UI MeSH Term Description Entries
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
Intravesical cisplatin for superficial bladder tumors.
September 1982, Cancer,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical chemotherapy of superficial bladder tumors].
February 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical chemotherapy in superficial tumors of the bladder].
February 1983, Ugeskrift for laeger,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical chemotherapy in superficial tumors of the bladder].
January 1983, Archivos espanoles de urologia,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
Intravesical mitoxantrone for superficial bladder tumors.
February 1994, Anti-cancer drugs,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical chemotherapy for superficial bladder tumors].
August 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical treatment of superficial tumors of the bladder].
October 1989, Presse medicale (Paris, France : 1983),
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
Intravesical chemotherapy in the management of superficial bladder tumors.
January 1984, Progress in clinical and biological research,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
Intravesical mitomycin C and superficial bladder tumors.
January 1989, Progress in clinical and biological research,
A Ojea, and J L Nogueira March, and L Figueiredo, and D Jamardo, and J Pérez Villanueva
[Intravesical chemotherapy with interferon in superficial bladder tumors].
April 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!